tiprankstipranks
InnoCan Pharma (TSE:INNO)
:INNO
Canadian Market
INNO
InnoCan Pharma
RESEARCH TOOLSreports

InnoCan Pharma (INNO) Ratios

22 Followers

InnoCan Pharma Ratios

TSE:INNO's free cash flow for Q4 2025 was $0.89. For the 2025 fiscal year, TSE:INNO's free cash flow was decreased by $ and operating cash flow was $0.28. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Mar 24Dec 22
Liquidity Ratios
Current Ratio
 7.70 7.70 4.09 2.68 9.41
Quick Ratio
 6.09 6.09 2.61 1.99 7.86
Cash Ratio
 4.94 4.94 2.24 1.53 6.77
Solvency Ratio
 -0.47 -0.47 -0.80 -1.83 -5.13
Operating Cash Flow Ratio
 0.37 0.37 -0.71 -1.54 -8.30
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 8.15M$ 8.15M$ 6.91M$ 4.25M$ 6.13M
Leverage Ratios
Debt-to-Assets Ratio
 0.09 0.09 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.17 0.17 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 0.14 0.14 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.14 0.14 0.00 0.00 0.00
Financial Leverage Ratio
 1.88 1.88 1.79 1.69 1.09
Debt Service Coverage Ratio
 -29.60 -98.67 -31.43 0.00 -1.93K
Interest Coverage Ratio
 -125.50 -418.33 -178.14 0.00 -3.13K
Debt to Market Cap
 0.04 0.04 0.00 0.00 0.00
Interest Debt Per Share
 0.21 0.21 <0.01 <0.01 <0.01
Net Debt to EBITDA
 -44.28 -44.28 -5.20 1.02 1.28
Profitability Margins
Gross Profit Margin
89.93%89.93%88.96%87.71%82.34%
EBIT Margin
0.33%0.33%3.15%-27.85%-151.86%
EBITDA Margin
0.49%0.49%3.26%-27.60%-150.49%
Operating Profit Margin
-4.72%-4.72%-4.24%27.85%-244.86%
Pretax Profit Margin
0.32%0.32%3.12%-29.54%-151.93%
Net Profit Margin
-4.22%-4.22%-6.23%-34.41%-151.97%
Continuous Operations Profit Margin
-1.28%-1.28%-0.89%-31.10%-151.97%
Net Income Per EBT
-1322.35%-1322.35%-199.56%116.51%100.03%
EBT Per EBIT
-6.77%-6.77%-73.70%-106.07%62.05%
Return on Assets (ROA)
-10.68%-10.68%-19.81%-67.72%-55.75%
Return on Equity (ROE)
-24.52%-20.08%-35.49%-114.55%-60.82%
Return on Capital Employed (ROCE)
-13.69%-13.69%-17.76%86.49%-100.34%
Return on Invested Capital (ROIC)
54.92%54.92%5.06%86.06%-100.11%
Return on Tangible Assets
-10.68%-10.68%-19.81%-67.72%-55.75%
Earnings Yield
-5.26%-5.15%-4.60%-8.03%-10.10%
Efficiency Ratios
Receivables Turnover
 28.19 28.19 117.75 54.85 41.27
Payables Turnover
 11.41 11.41 17.57 14.99 4.76
Inventory Turnover
 1.23 1.23 0.98 0.96 0.40
Fixed Asset Turnover
 309.44 309.44 260.50 100.42 26.11
Asset Turnover
 2.53 2.53 3.18 1.97 0.37
Working Capital Turnover Ratio
 3.10 3.33 5.27 2.62 0.34
Cash Conversion Cycle
 277.61 277.61 354.85 362.09 845.44
Days of Sales Outstanding
 12.95 12.95 3.10 6.65 8.84
Days of Inventory Outstanding
 296.66 296.66 372.52 379.78 913.31
Days of Payables Outstanding
 31.99 31.99 20.78 24.35 76.71
Operating Cycle
 309.60 309.60 375.62 386.44 922.15
Cash Flow Ratios
Operating Cash Flow Per Share
 0.11 0.11 -0.38 -1.01 -1.62
Free Cash Flow Per Share
 0.11 0.11 -0.38 -1.02 -1.63
CapEx Per Share
 <0.01 <0.01 <0.01 0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.97 0.97 1.01 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
 30.94 30.94 -105.27 -84.87 -233.35
Capital Expenditure Coverage Ratio
 30.94 30.94 -105.27 -84.87 -233.35
Operating Cash Flow Coverage Ratio
 0.53 0.53 -157.90 -118.30 -178.44
Operating Cash Flow to Sales Ratio
 0.02 0.02 -0.05 -0.29 -2.37
Free Cash Flow Yield
2.23%2.19%-4.00%-6.74%-15.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -19.02 -19.43 -21.73 -12.46 -9.90
Price-to-Sales (P/S) Ratio
 0.81 0.82 1.35 4.29 15.05
Price-to-Book (P/B) Ratio
 3.82 3.90 7.71 14.27 6.02
Price-to-Free Cash Flow (P/FCF) Ratio
 44.85 45.60 -25.00 -14.83 -6.32
Price-to-Operating Cash Flow Ratio
 43.19 44.13 -25.23 -15.00 -6.35
Price-to-Earnings Growth (PEG) Ratio
 -0.29 0.48 0.34 -0.72 0.15
Price-to-Fair Value
 3.82 3.90 7.71 14.27 6.02
Enterprise Value Multiple
 120.96 123.74 36.26 -14.51 -8.72
Enterprise Value
 15.73M 16.09M 34.85M 54.71M 33.60M
EV to EBITDA
 121.00 123.74 36.26 -14.51 -8.72
EV to Sales
 0.59 0.60 1.18 4.01 13.13
EV to Free Cash Flow
 32.84 33.58 -21.86 -13.85 -5.51
EV to Operating Cash Flow
 31.78 32.50 -22.07 -14.01 -5.54
Tangible Book Value Per Share
 1.84 1.84 1.67 1.14 1.67
Shareholders’ Equity Per Share
 1.25 1.25 1.23 1.06 1.71
Tax and Other Ratios
Effective Tax Rate
 5.01 5.01 1.29 -0.05 >-0.01
Revenue Per Share
 5.94 5.94 7.01 3.54 0.69
Net Income Per Share
 -0.25 -0.25 -0.44 -1.22 -1.04
Tax Burden
 -13.22 -13.22 -2.00 1.17 1.00
Interest Burden
 0.97 0.97 0.99 1.06 1.00
Research & Development to Revenue
 0.04 0.04 0.05 0.13 0.60
SG&A to Revenue
 0.91 0.91 0.88 0.23 1.56
Stock-Based Compensation to Revenue
 0.05 0.05 0.07 0.06 0.38
Income Quality
 -1.45 -1.45 6.03 0.83 1.56
Currency in USD